3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma, Cutaneous Malignant
1
Interventions
pembrolizumab
3
Paclitaxel
2
relatlimab
1
nintedanib
1
lifileucel
1
dabrafenib
1
Vitamin D
1
Temozolomide
1
Surveys and Questionnaires
1
Opdualag
1
Nivolumab
1
Microarray Analysis
1
Ipilimumab
1
Genetic Testing
1
Gene Expression Profiling
1
Eye Movement Desensitization Reprocessing
1
Electrochemotherapy
1
Dacarbazine
1
Cholecalciferol
1
Carboplatin
1
Biopsy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Melanoma, Cutaneous Malignant
×
nintedanib
×
Dermatologic
×
Clear all
NCT02308553
2020-10-14
NIPAWILMA
University Hospital, Essen
Phase 1/2
Completed
33 enrolled